The 2012 Christmas Book was unveiled today by luxury retailer Neiman Marcus in Dallas. The 86th edition of this legendary book continues Neiman Marcus’s unmatched tradition of offering its customers a selection of spectacular and unique holiday gifts sure to make even their wildest dreams come true.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57191-2012-neiman-marcus-christmas-book
The 2015 Christmas Book was unveiled today by luxury retailer Neiman Marcus in Dallas. The 89th edition of this legendary book continues Neiman Marcus’s unmatched tradition of offering its customers a selection of spectacular and unique holiday gifts sure to make even their wildest dreams come true.
ARCH MOTORCYCLE & RIDE EXPERIENCE
Keanu Reeves and Gard Hollinger make up Arch Motorcycle Company, and the KRGT-1—hailed by one reviewer as “the Zen of motorcycle design”—is their first production bike. Framed of steel and aircraft-grade billet aluminum with carbon fiber fenders and front cowling, it has a 124-cubic-inch v-twin engine that produces 121 horsepower and matching 120 pound-feet of torque. This limited edition comes with custom race-inspired trim, performance suspension, and an exclusive two-day ride experience for two along the California coast with Reeves and Hollinger. Hotel and airfare to California included. With the purchase of the KRGT-1 Motorcycle Ride Experience, Neiman Marcus will donate $5,000 to The Heart of Neiman Marcus Foundation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7561451-neiman-marcus-2015-christmas-book/
Homewood Suites by Hilton, the international brand of the all-suite, home-like hotels, today launched an integrated brand awareness campaign starring the brand’s beloved “Lewis the Duck” mascot and its suites with full kitchens. The campaign includes TV, print, and online ads, as well as a Duckmentary chronicling Lewis’ TV ad shoot, which will serve as the centerpiece for a corresponding social media and public relations campaign.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/homewood-suites/48873
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
